KAMRAN AHRAR to von Hippel-Lindau Disease
This is a "connection" page, showing publications KAMRAN AHRAR has written about von Hippel-Lindau Disease.
Connection Strength
0.217
-
Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial. Lancet Oncol. 2018 10; 19(10):1351-1359.
Score: 0.146
-
Patterns of intervention for renal lesions in von Hippel-Lindau disease. BJU Int. 2008 Sep; 102(8):940-5.
Score: 0.071